All Stories

  1. 3D Carbon-Nanotube-Based Composites for Cardiac Tissue Engineering

    Article • ACS Applied Bio Materials, October 2018, American Chemical Society (ACS)

    Dr. Luisa Mestroni

  2. Carbon Nanotube Facilitation of Myocardial Ablation with Radiofrequency Energy

    Article • Journal of Cardiovascular Electrophysiology, September 2014, Wiley

    Dr. Luisa Mestroni

  3. Decreased Levels of BAG3 in a Family With a Rare Variant and in Idiopathic Dilated Cardiomyopathy

    Article • Journal of Cellular Physiology, July 2014, Wiley

    Dr. Luisa Mestroni

  4. Exploring the elasticity and adhesion behavior of cardiac fibroblasts by atomic force microscopy indentation

    Article • Materials Science and Engineering C, July 2014, Elsevier

    Dr. Luisa Mestroni

  5. Family Members of Patients With ARVC

    Article • Journal of the American College of Cardiology, July 2014, Elsevier

    Dr. Luisa Mestroni

  6. Pharmacogenetics of heart failure

    Article • Current Opinion in Cardiology, May 2014, Wolters Kluwer Health

    Dr. Luisa Mestroni

  7. Inhibition of Proto-Oncogene c-Src Tyrosine Kinase

    Article • Journal of the American College of Cardiology, March 2014, Elsevier

    Dr. Luisa Mestroni

  8. Genetics and Genomics for the Prevention and Treatment of Cardiovascular Disease: Update

    Article • Circulation, December 2013, Wolters Kluwer Health

    Dr. Luisa Mestroni

  9. Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy

    Article • PLoS ONE, October 2013, PLOS

    Dr. Luisa Mestroni

  10. Poor Prognosis of Rare Sarcomeric Gene Variants in Patients with Dilated Cardiomyopathy

    Article • Clinical and Translational Science, October 2013, Wiley

    Dr. Luisa Mestroni

  11. Cardiac Hypertrophy, Accessory Pathway, and Conduction System Disease in an Adolescent

    Article • Journal of the American College of Cardiology, August 2013, Elsevier

    Dr. Luisa Mestroni

  12. Atomic force microscopy of 3T3 and SW-13 cell lines: An investigation of cell elasticity changes due to fixation

    Article • Materials Science and Engineering C, August 2013, Elsevier

    Dr. Luisa Mestroni

  13. Carbon Nanotubes Instruct Physiological Growth and Functionally Mature Syncytia: Nongenetic Engineering of Cardiac Myocytes

    Article • ACS Nano, June 2013, American Chemical Society (ACS)

    Dr. Luisa Mestroni

  14. Improving cardiac myocytes performance by carbon nanotubes platforms†

    Article • Frontiers in Physiology, January 2013, Frontiers

    Dr. Luisa Mestroni

  15. Utility of Cardiac Magnetic Resonance Imaging to Differentiate Cardiac Sarcoidosis from Arrhythmogenic Right Ventricular Cardiomyopathy

    Article • The American Journal of Cardiology, August 2012, Elsevier

    Dr. Luisa Mestroni

  16. Carbon Nanotubes Promote Growth and Spontaneous Electrical Activity in Cultured Cardiac Myocytes

    Article • Nano Letters, March 2012, American Chemical Society (ACS)

    Dr. Luisa Mestroni

  17. Truncations of Titin Causing Dilated Cardiomyopathy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2012, New England Journal of Medicine (NEJM/MMS)

    Dr. Luisa Mestroni

  18. Sudden Death Associated With Danon Disease in Women

    Article • The American Journal of Cardiology, February 2012, Elsevier

    Dr. Luisa Mestroni

  19. High-throughput Genotyping Robot-assisted Method for Mutation Detection in Patients With Hypertrophic Cardiomyopathy

    Article • Diagnostic Molecular Pathology, September 2011, Wolters Kluwer Health

    Dr. Luisa Mestroni

  20. Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes

    Article • Circulation, August 2011, Wolters Kluwer Health

    Dr. Luisa Mestroni

  21. Hearing the Noise

    Article • Journal of the American College of Cardiology, June 2011, Elsevier

    Dr. Luisa Mestroni

  22. SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism

    Article • Journal of the American College of Cardiology, May 2011, Elsevier

    Dr. Luisa Mestroni

  23. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry

    Article • European Heart Journal, February 2011, European Society of Cardiology

    Dr. Luisa Mestroni

  24. Heart failure and personalized medicine

    Article • Journal of Cardiovascular Medicine, January 2011, Wolters Kluwer Health

    Dr. Luisa Mestroni

  25. Prognostic impact of familial screening in dilated cardiomyopathy

    Article • European Journal of Heart Failure, September 2010, Wiley

    Professor Dario Gregori, Dr. Luisa Mestroni

  26. Phenotypic Heterogeneity of Sarcomeric Gene Mutations

    Article • Journal of the American College of Cardiology, July 2009, Elsevier

    Dr. Luisa Mestroni

  27. Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline

    Article • Journal of Cardiac Failure, March 2009, Elsevier

    Dr. Luisa Mestroni

  28. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure

    Article • Pharmacogenetics and Genomics, January 2009, Wolters Kluwer Health

    Laura Lazzeroni, Dr. Luisa Mestroni

  29. Lamin A/C Gene and the Heart

    Article • Journal of the American College of Cardiology, October 2008, Elsevier

    Dr. Luisa Mestroni

  30. Cardiomyopathy and carnitine deficiency

    Article • Molecular Genetics and Metabolism, June 2008, Elsevier

    Dr. Luisa Mestroni

  31. The challenge of cardiomyopathies in 2007

    Article • Journal of Cardiovascular Medicine, June 2008, Wolters Kluwer Health

    Dr. Luisa Mestroni

  32. Are Nonsustained Ventricular Tachycardias Predictive of Major Arrhythmias in Patients with Dilated Cardiomyopathy on Optimal Medical Treatment?

    Article • Pacing and Clinical Electrophysiology, March 2008, Wiley

    Professor Dario Gregori, Dr. Luisa Mestroni

  33. Danon disease presenting with dilated cardiomyopathy and a complex phenotype

    Article • Journal of Human Genetics, September 2007, Springer Science + Business Media

    Dr. Luisa Mestroni

  34. Prevalence of Desmin Mutations in Dilated Cardiomyopathy

    Article • Circulation, March 2007, Wolters Kluwer Health

    Dr. Luisa Mestroni

  35. Ophthalmic Manifestations of Danon Disease

    Article • Ophthalmology, June 2006, Elsevier

    Dr. Luisa Mestroni

  36. Article • Orphanet Journal of Rare Diseases, January 2006, Springer Science + Business Media

    Dr. Luisa Mestroni

  37. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy

    Article • Human Mutation, December 2005, Wiley

    Dr. Luisa Mestroni

  38. α-Myosin Heavy Chain

    Article • Circulation, July 2005, Wolters Kluwer Health

    Dr. Luisa Mestroni

  39. Drug Therapy in the Heart Transplant Recipient

    Article • Circulation, December 2004, Wolters Kluwer Health

    Dr. Luisa Mestroni

  40. Drug Therapy in the Heart Transplant Recipient

    Article • Circulation, December 2004, Wolters Kluwer Health

    Dr. Luisa Mestroni

  41. SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia

    Article • Circulation, October 2004, Wolters Kluwer Health

    Dr. Luisa Mestroni

  42. Analysis of Genetic Variations of Lamin A/C Gene (LMNA) by Denaturing High-Performance Liquid Chromatography

    Article • October 2004, SAGE Publications

    Dr. Luisa Mestroni

  43. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing

    Article • Expert Review of Molecular Diagnostics, January 2004, Taylor & Francis

    Dr. Luisa Mestroni

  44. Familial Dilated Cardiomyopathy

    Article • Circulation, October 2003, Wolters Kluwer Health

    Dr. Luisa Mestroni

  45. Genomic medicine and atrial fibrillation**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.

    Article • Journal of the American College of Cardiology, June 2003, Elsevier

    Dr. Luisa Mestroni

  46. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Dr. Luisa Mestroni

  47. Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement

    Article • Circulation, February 2000, Wolters Kluwer Health

    Dr. Luisa Mestroni

  48. Familial dilated cardiomyopathy

    Article • Journal of the American College of Cardiology, July 1999, Elsevier

    Professor Dario Gregori, Dr. Luisa Mestroni

  49. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol

    Article • Journal of the American College of Cardiology, June 1999, Elsevier

    Professor Dario Gregori, Dr. Luisa Mestroni

  50. Guidelines for the study of familial dilated cardiomyopathies

    Article • European Heart Journal, January 1999, European Society of Cardiology

    Dr. Luisa Mestroni

  51. ADVANCES IN MOLECULAR GENETICS OF DILATED CARDIOMYOPATHY

    Article • Cardiology Clinics, November 1998, Elsevier

    Dr. Luisa Mestroni

  52. Dilated cardiomyopathy: a genetic approach.

    Article • Heart, March 1997, BMJ

    Dr. Luisa Mestroni

  53. A Point Mutation in the 5' Splice Site of the Dystrophin Gene First Intron Responsible for X-Linked Dilated Cardiomyopathy

    Article • Human Molecular Genetics, January 1996, Oxford University Press (OUP)

    Prof Corrado Angelini, Dr. Luisa Mestroni

  54. A New Locus for Arrhythmogenic Right Ventricular Dysplasia on the Long Arm of Chromosome 14

    Article • Genomics, January 1996, Elsevier

    Dr. Luisa Mestroni

  55. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart.

    Article • Journal of Clinical Investigation, August 1995, American Society for Clinical Investigation

    Dr. Luisa Mestroni

  56. Familial dilated cardiomyopathy

    Article • Heart, December 1994, BMJ

    Dr. Luisa Mestroni

  57. Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.

    Article • Journal of Medical Genetics, October 1994, BMJ

    Dr. Luisa Mestroni

  58. Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy

    Article • Journal of the American College of Cardiology, October 1994, Elsevier

    Dr. Luisa Mestroni

  59. Evidence from family studies for autoimmunity in dilated cardiomyopathy

    Article • The Lancet, September 1994, Elsevier

    Dr. Luisa Mestroni

  60. Parental origin of the X chromosome in a patient with a Robertsonian translocation and Turner's syndrome.

    Article • Journal of Medical Genetics, March 1994, BMJ

    Dr. Luisa Mestroni

  61. Clinical and pathologic study of familial dilated cardiomyopathy

    Article • The American Journal of Cardiology, June 1990, Elsevier

    Dr. Luisa Mestroni

  62. Correlation between histomorphometric findings on endomyocardial biopsy and clinical findings in idiopathic dilated cardiomyopathy

    Article • The American Journal of Cardiology, September 1989, Elsevier

    Dr. Luisa Mestroni

  63. Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone

    Article • American Heart Journal, March 1987, Elsevier

    Dr. Luisa Mestroni

  64. Arrhythmias in dilated cardiomyopathy.

    Article • Postgraduate Medical Journal, June 1986, BMJ

    Dr. Luisa Mestroni